Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.01% Nasdaq Up0.31%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
53.23 Down 0.27(0.50%) 10:30AM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development22,544  16,063  15,816  12,122  
Selling General and Administrative5,950  4,312  3,492  3,218  
Non Recurring -   -   -  250  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (28,494) (20,375) (19,308) (15,590)
Income from Continuing Operations
Total Other Income/Expenses Net(657)55  (33)(78)
Earnings Before Interest And Taxes(29,151)(20,320)(19,341)(15,668)
Interest Expense -   -   -   -  
Income Before Tax(29,151)(20,320)(19,341)(15,668)
Income Tax Expense52   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(29,203)(20,320)(19,341)(15,668)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (29,203) (20,320) (19,341) (15,668)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (29,203) (20,320) (19,341) (15,668)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.